Insights Home Insights Featured Content Case Study- Technology Case Study: Lithium-Ion Battery Expert Needed for ITC Investigation The complainants approached WIT to provide an expert with extensive knowledge and experience in the relatively narrow field of lithium-ion battery separators, particularly those that were commercially available and utilized in the industry between 2005 and 2008. Article Q1 Litigation Review: Expert Insights on the Wireless, Automotive, and Gaming Industries To understand where legal disputes may lie in 2024, we asked some of our esteemed experts to offer insights on the trajectory of their industry as technology continues to rapidly evolve. Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask. Report 2023 in Review: Analyzing Hatch-Waxman Litigation Trends Our inaugural Hatch-Waxman report, 2023 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2023’s activities and trends in Hatch-Waxman litigation. Blog An Expert’s Look at the Wireless Industry Legal Landscape in 2024 What’s to come in the wireless sector for 2024? We asked WIT wireless expert Dr. Muriel Medard to evaluate the industry with regard to 5G technology, industry innovation, and more. Insights & News All Industries Automotive Biotechnology Financial Technology Gaming Healthcare Technology Pharmaceutical Wireless Communications All Trends 2023 Banking Crisis 5G / 6G COVID-19 Cryptocurrency Drug and Vaccine Development Election Law and Voting Rights Electric Vehicles FDA-Regulated Drugs and Devices Lab-Grown Foods Mobile Gaming Payment Systems Virtual Reality Wearable Devices All Insight Types Archive Article Blog Case Study Case Study- Life Sciences Case Study- Technology Event In the News Other Content Press Release Report Video Search March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask. March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue. December 19, 2023 — Blog Maximizing the Impact of Expert Witnesses in Legal Proceedings Whether it's a business-savvy c-suite executive, highly-credentialed academic, knowledgeable industry insider, or technical specialist, experts can make all the difference in achieving a favorable outcome in a case. August 1, 2023 — In the News Rough Waters Ahead: Proposed Antitrust Guidelines Spell Trouble for Big Tech, Big Pharma, and More As the FTC and DOJ attempt to slow anticompetitive practices in the tech space, life sciences sector, and more, how will these regulators' latest proposal affect M&As among major industry players if it comes to pass? July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies. May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process? May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more. April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets. Blog Five Reasons Why Attorneys Should Look Beyond a Stack of CVs When Considering Experts Too often, law firms relegate finding experts to “search” firms who send over a stack of CVs with the expectation of finding an expert that is “good enough” for a case. Not only is that inefficient, but also problematic. Other Content Juror Attitudes Toward Pharmaceutical Companies A DOAR Research Center report commissioned by WIT reveals important findings from a new survey assessing attitudes toward pharmaceutical companies by potential jurors. Load More Loading...
Case Study- Technology Case Study: Lithium-Ion Battery Expert Needed for ITC Investigation The complainants approached WIT to provide an expert with extensive knowledge and experience in the relatively narrow field of lithium-ion battery separators, particularly those that were commercially available and utilized in the industry between 2005 and 2008.
Article Q1 Litigation Review: Expert Insights on the Wireless, Automotive, and Gaming Industries To understand where legal disputes may lie in 2024, we asked some of our esteemed experts to offer insights on the trajectory of their industry as technology continues to rapidly evolve.
Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask.
Report 2023 in Review: Analyzing Hatch-Waxman Litigation Trends Our inaugural Hatch-Waxman report, 2023 in Review: Analyzing Hatch-Waxman Litigation Trends, provides a comprehensive look at 2023’s activities and trends in Hatch-Waxman litigation.
Blog An Expert’s Look at the Wireless Industry Legal Landscape in 2024 What’s to come in the wireless sector for 2024? We asked WIT wireless expert Dr. Muriel Medard to evaluate the industry with regard to 5G technology, industry innovation, and more.
March 22, 2024 — Case Study- Life Sciences Case Study: Experienced Urologist Needed for ANDA IP Infringement Dispute The defendant approached WIT to provide an expert who could help bring their drug to market and invalidate the claims of the plaintiff. This case called for an expert who possessed a deep understanding of renal cell carcinoma (kidney cancer). Let's see how WIT was able to meet the ask.
March 20, 2024 — Press Release WIT Legal Releases New Report on 2023 Activities and Trends in Hatch-Waxman Litigation The report examines Abbreviated New Drug Application (ANDA) cases and the Orange Book-listed products at issue.
December 19, 2023 — Blog Maximizing the Impact of Expert Witnesses in Legal Proceedings Whether it's a business-savvy c-suite executive, highly-credentialed academic, knowledgeable industry insider, or technical specialist, experts can make all the difference in achieving a favorable outcome in a case.
August 1, 2023 — In the News Rough Waters Ahead: Proposed Antitrust Guidelines Spell Trouble for Big Tech, Big Pharma, and More As the FTC and DOJ attempt to slow anticompetitive practices in the tech space, life sciences sector, and more, how will these regulators' latest proposal affect M&As among major industry players if it comes to pass?
July 26, 2023 — Blog Big Pharma’s Balancing Act: Navigating Patent Thickets in the Age of Biosimilars Biosimilar patent cases are complex legal battles that require the support of various experts to bolster the nuanced arguments presented by pharmaceutical companies.
May 24, 2023 — In the News Will the FTC’s Amgen Suit Ignite Future Pharmaceutical M&A Conflicts? With M&A activity in the life sciences sector heating up, the latest dispute in the space may affect the future of pharmaceutical acquisitions. How will the FTC's recent case against Amgen ignite future M&A conflicts, and where can experts assist in the litigation process?
May 17, 2023 — Article Retaining Experts for Three Top Trends in Life Sciences in 2023 What are three growing trends in life sciences with legal implications, their drivers, and the types of experts that would be advantageous to retain? Learn more.
April 4, 2023 — Press Release WIT Legal Expands Life Sciences Practice to Address Increase in Litigation Targeting Pharmaceutical, Biotechnology, and Healthcare Technology Companies The company has a reputation for building diverse teams of leading experts across trending areas of litigation and is committed to affiliating with the most qualified experts in emerging markets.
Blog Five Reasons Why Attorneys Should Look Beyond a Stack of CVs When Considering Experts Too often, law firms relegate finding experts to “search” firms who send over a stack of CVs with the expectation of finding an expert that is “good enough” for a case. Not only is that inefficient, but also problematic.
Other Content Juror Attitudes Toward Pharmaceutical Companies A DOAR Research Center report commissioned by WIT reveals important findings from a new survey assessing attitudes toward pharmaceutical companies by potential jurors.